XtalPi scores landmark deal for AI drug discovery
The biotech has partnered with U.S. firm DoveTree in a collaboration worth up to $5.99 billion, adding to a slew of major deals for Chinese research firms this year Key…
Recent Articles
RELATED ARTICLES
-
RemeGen’s $4.2 billion licensing deal falls flat with investors
9995.HK688331.SHG
